Brainsway (BWAY) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BrainsWay Ltd. has announced the expansion of its Deep TMS treatment in Israel, driven by a recent 45% increase in reimbursement rates and the installation of 11 new systems, with more expected by the end of 2024. The company aims to provide its noninvasive neurostimulation treatments to a growing number of mental health patients, responding to the rising need for alternative therapies in the country.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.